Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination  by Emery, Ben et al.
Myelin Gene Regulatory Factor Is a
Critical Transcriptional Regulator
Required for CNS Myelination
Ben Emery,1,* Dritan Agalliu,1 John D. Cahoy,1 Trent A. Watkins,1 Jason C. Dugas,1 Sara B. Mulinyawe,1 Adilijan Ibrahim,1
Keith L. Ligon,2 David H. Rowitch,3 and Ben A. Barres1
1Department of Neurobiology, Stanford University School of Medicine, Stanford, CA 94305-5125, USA
2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
3Department of Pediatrics, Howard HughesMedical Institute and Institute for Regeneration Medicine, University of California, San Francisco,
San Francisco, CA 94143-0734, USA
*Correspondence: bemery@stanford.edu
DOI 10.1016/j.cell.2009.04.031SUMMARY
The transcriptional control of CNS myelin gene
expression is poorly understood. Here we identify
gene model 98, which we have named myelin gene
regulatory factor (MRF), as a transcriptional regulator
required for CNSmyelination.Within the CNS,MRF is
specifically expressed by postmitotic oligodendro-
cytes. MRF is a nuclear protein containing an evolu-
tionarily conservedDNAbindingdomain homologous
to a yeast transcription factor. Knockdown of MRF in
oligodendrocytes by RNA interference prevents
expression of most CNS myelin genes; conversely,
overexpression of MRF within cultured oligodendro-
cyte progenitors or the chick spinal cord promotes
expression of myelin genes. In mice lacking MRF
within the oligodendrocyte lineage, premyelinating
oligodendrocytes are generated but display severe
deficits in myelin gene expression and fail to myeli-
nate. These mice display severe neurological abnor-
malities and die because of seizures during the third
postnatal week. These findings establish MRF as a
critical transcriptional regulator essential for oligo-
dendrocyte maturation and CNS myelination.
INTRODUCTION
Myelination in vertebrates has evolved to insulate axons and
promote rapid propagation of action potentials. Within the
CNS, this function is carried out by oligodendrocytes (OLs).
Developmentally, committed OL progenitor cells (OPCs) arise
from stereotyped germinal regions of the CNS, proliferate, and
migrate throughout the CNS before differentiating into postmi-
totic premyelinating OLs. These premyelinating OLs subse-
quently either upregulate myelin genes and ensheath adjacent
axons or undergo apoptosis. Several transcription factors are
required for the specification of OPCs or their subsequent
differentiation into postmitotic OLs, such as Nkx2.2, Sox10,172 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.and the bHLH proteins Olig1/2. (Fu et al., 2002; Kuhlbrodt
et al., 1998; Lu et al., 2000; Qi et al., 2001; Stolt et al., 2002;
Zhou et al., 2001). Among these, Olig2 is the only gene necessary
for the OL lineage specification, with Olig2/ mice showing
a loss of PDGFRa-positive OPCs within most of the CNS (Lu
et al., 2002; Zhou and Anderson, 2002). In contrast, mutants
for Olig1, Sox10, and Nkx2.2 have only mild defects in OPC
generation, but show impaired oligodendrocyte differentiation
and myelin gene expression (Qi et al., 2001; Stolt et al., 2002;
Xin et al., 2005). More recently Yin Yang1 (YY1) has also been
demonstrated to play an important role in oligodendrocyte differ-
entiation (He et al., 2007).
Few transcription factors function specifically at the postmi-
totic stage of the OL lineage, and those that do (e.g., Nkx6.2)
(Southwood et al., 2004), do not appear to be necessary for
most aspects of myelination. It is thus unclear whether the
known oligodendrocyte lineage transcription factors play a
dual role in oligodendrocyte differentiation and myelination, or
instead are required only for oligodendrocyte differentiation,
with other yet-to-be-identified transcription factors playing
essential roles in inducing myelin gene expression and the tran-
sition to a myelinating OL. This situation contrasts with that of
PNS myelination, where the transcription factor Krox-20 (ex-
pressed in myelinating Schwann cells) is both sufficient and
necessary to induce myelin gene expression and myelination
in these cells (Nagarajan et al., 2001; Topilko et al., 1994).
As such, the nature of transcriptional control of the final stages
of OL maturation including myelin gene expression remains
unclear.
In a recent study, we determined the transcriptomes of acutely
isolated astrocytes, neurons, and OLs from the postnatal mouse
forebrain (Cahoy et al., 2008). We identified gene model 98 as
a gene expressed within the CNS only by postmitotic OLs.
Here, we demonstrate that gene model 98, which we have
named myelin gene regulatory factor (MRF), is necessary for
the generation of mature myelin-gene-expressing OLs within
the CNS. RNAi-mediated knockdown of MRF in cultured OPCs
does not affect their exit from the cell cycle and downregulation
of OPC markers, but markedly reduces the expression of the
majority of myelin genes. Conversely, overexpression of MRF
within cultured OPCs is sufficient to induce myelin gene expres-
sion, and it can promote myelin gene expression in the devel-
oping chick spinal cord. Moreover, we show that mice in which
MRF function is disrupted within the OL lineage show severe
dysmyelination. Although premyelinating OLs are generated in
these mice, these premyelinating OLs fail to upregulate myelin
gene expression and ensheath axons, and instead undergo
apoptosis. These results establishMRF as a transcriptional regu-
lator vital for the generation of myelinating OLs, with an analo-
gous role in the CNS to that of Krox-20 in the PNS.
RESULTS
GM98/MRF Is an OL-Specific Nuclear
Protein within the CNS
We used an immunopanning/FACS cell purification approach
combined with gene profiling in order to identify cell-type-
specific genes within the mouse CNS (Cahoy et al., 2008).
Among the genes displaying OL-specific expression was gene
model 98. The Affymetrix probe set for this gene was absent in
samples derived from astrocytes and neurons, present at very
low levels in OPCs, but upregulated in newly differentiated
(GC+, MOG) andmature (MOG+) OLs (Figure 1A). Northern blot-
ting confirmed that MRFwas present in brain and OL samples as
a 5.5 kb transcript, consistent with database predictions (Fig-
ure 1B). In situ hybridization showed that MRF displayed the
same distribution as the established OL marker PLP, with
expression largely confined to white matter tracts within the
CNS (Figure 1C). The expression of MRF by myelinating cells
was CNS specific, with no expression detected in the PNS
(Figure S1 available online).
Sequencing of cDNA derived from cultured mouse OLs pre-
dicted a protein of 1139 amino acids, with an overall identity of
88.6% to the human gene C11Orf9 (Figure S2). The protein con-
tained a predicted DNA binding region homologous to the yeast
transcription factor Ndt80 (Montano et al., 2002); within this
region, MRF and C11Orf9 shared 100% sequence identity
(Figure 1D). C11Orf9 has been postulated to be a transmem-
brane protein based on the presence of hydrophobic regions in
the C-terminal region (Stohr et al., 2000). In order to assess the
subcellular localization of MRF, we expressed a myc-tagged
version of the protein and probed with anti-myc; the fusion
protein had a nuclear localization when expressed in both HEK
cells (Figure 1E) and cultured OLs (data not shown). These
data provide evidence that MRF is a nuclear protein displaying
OL-specific expression within the CNS.
In order to assess whether MRF displayed a developmental
expression profile consistent with a role in myelination, we per-
formed in situ hybridization on brain sections ofmice at postnatal
days 3 to 21. At P3, the expression of MRFwas restricted to cells
in the hindbrain and cerebellum, subsequently spreading
rostrally throughout the whitematter tracks over the first 2 weeks
postnatal, mirroring the expression of PLP (Figure 1F). Dual fluo-
rescent in situ hybridization forMRF and PLP revealed that within
the cerebellum at early ages (P3 and P7), many MRF+ cells were
either PLP or only weakly PLP+ (arrowheads, Figure 1G). At later
ages (P14 and P21), however, the two genes showed near 100%
colocalization. This suggests that the expression of MRF mayslightly precede that of myelin genes such as PLPwithin differen-
tiating oligodendrocytes. Similarly, northern blots revealed that
MRF transcript was absent in the P1 brain but steadily increased
from P3 to P14, peaking in expression before PLP transcript
(Figure S1). Within the embryonic spinal cord, a few MRF+ cells
were detected by E17, in a pattern similar to PLP and MBP
(Figure S1). These results confirmed that MRF has an expression
pattern consistent with a potential role in myelination.
Knockdown of MRF in Cultured OLs Blocks
Myelin Gene Expression
To establish whetherMRFmay have a role in OL differentiation or
myelin gene expression, we transfected cultured mouse OPCs
with control nontargeting siRNA pool (siCont) or pooled siRNAs
against MRF (siMRF). Knockdown of MRF was confirmed by
northern blot and RT-PCR (Figure 2E and data not shown).
siMRF-transfected OPCs displayed no obvious deficiencies
when cultured in the presence of PDGF, which promotes the
growth of progenitor cells (data not shown). When transfected
OPCs were instead plated into media lacking PDGF and with
T3 to induce their differentiation into OLs (Dugas et al., 2006),
the siMRF-transfected cells showed both delayed and reduced
levels of MBP expression relative to siCont-transfected cells
and failed to express MOG even after 4 days of differentiation,
by which time the majority of siCont-transfected cells expressed
MOG (Figures 2A–2D). This failure of siMRF-transfected cells to
express MBP andMOGwas not due to a failure of differentiation
per se or a diversion to an astrocyte fate; the siMRF-transfected
cells still downregulated the OPC marker NG2, did not express
the astrocyte marker GFAP, were positive for the OL marker
GalC, and took on the multipolar morphology characteristic of
OLs, albeit with far less extensive membrane sheets than si-
Cont-transfected cells (Figure S3C). This effect was unlikely to
be mediated by off-target siRNA effects, because it was
observed with 2 of 4 independent nonoverlapping siRNA
constructs targeting MRF (Figure S3E). Interestingly, after
2 days of differentiation, the MRF knockdown resulted in an in-
creased apoptosis relative to siCont-transfected cells (Fig-
ure S3). Although mouse OLs have a limited viability in culture
after differentiation with few cells surviving more than a week,
the rate of apoptosis was accelerated in cells transfected with
siMRF compared to siCont. Furthermore, siMRF-transfected
cells showed decreased expression of other myelin genes
CNP and PLP (Figure 2D).
To further characterize the changes in gene expression result-
ing from inhibition of MRF expression, we performed GeneChip
analysis between OL cultures differentiated for 2 days after
transfection with siCont or siMRF and OPC cultures that served
as ameasure of baseline gene expression prior to differentiation.
The GeneChip analysis confirmed that upon differentiation both
siCont- and siMRF-transfected cultures completely downregu-
lated OPC markers (e.g., NG2, PDGFRa, and Ki67) (Figure 2F).
In addition, siMRF-transfected cultures failed to induce most
myelin genes, with the expression of late phase genes such as
MAG and MOBP being entirely blocked (the 50 most repressed
genes by siMRF are listed in Table S1) relative to the siCont
cultures. Most early OL genes such as MBP and PLP were also
inhibited, though to a lesser extent, and pan-OL lineage genesCell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc. 173
Figure 1. GM98/MRF Is a Nuclear Protein Specifically Expressed within the CNS by Postmitotic OLS
(A) Affymetrix expression levels of GM98/MRF in acutely isolated cells from the mouse CNS (probe set 1439506_at). Expression was considered present by
GCOS software for the OPC, GalC+ OL, and MOG+ OL samples.
(B) Northern blot confirmed expression of MRF as a single 5.5 Kb transcript within P20 brain and cultured OLs, but not heart tissue, similar to OL marker CNP.
GAPDH controls for mRNA loading.
(C) In situ hybridization for PLP and MRF expression within the lateral corpus callosum (cc) and scattered cells in the overlying cortex. Scale bar represents
100 mm.
(D) Schematic of the protein domains of GM98/MRF and the human ortholog C11Orf9, showing percent identity in each region.
(E) Subcellular localization of myc-tagged MRF within HEK cells. Staining of Myc-MRF-transfected HEK cells with anti-myc indicates a predominantly nuclear
localization of the protein, with colocalization with the nuclear counterstain DAPI in transfected cells. Non-myc-taggedMRF and amyc-tagged protein displaying
a cytoplasmic localization provide a negative control for the staining and a comparison, respectively. Scale bar represents 50 mm.
(F) In situ hybridization for MRF and PLP in P3-21 sagittal brain sections showing their developmental expression profile.
(G) Double fluorescent in situ hybridization for MRF and PLP in the white matter of the developing cerebellum (P3–P21); arrowheads indicate MRF+/PLP cells.such as Sox10, Olig1, and Olig2 were unaffected by the MRF
knockdown (Figure 2G). Interestingly, when the genes repressed
4-fold or more by the MRF knockdown were compared to the
genes induced during OL differentiation (between OPC and
siCont samples), the majority of genes dependent on MRF174 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.expressionwere genes usually induced specifically in OLs during
their differentiation (104 of 128 probe sets). MRF-regulated
genes represented only a subset of genes that are normally
induced during OL differentiation (104 of 793 probe sets),
whereas the expression of other OL-specific genes such as
Figure 2. Knockdown of MRF in OLs Blocks Myelin Gene Expression
(A and B) Representative images of OL cultures transfected with siCont or siMRF and differentiated for 1, 2, and 4 days stained with NG2 andMBP (A) orMOG (B).
Scale bars represent 50 mm.
(C and D) Quantification of the proportion of siCont- and siMRF-transfected OLs expressing MBP (C) and MOG (D) at 1, 2, and 4 days differentiation. **p < 0.01.
(E) Northern blot analysis of gene expression in siCont- and siMRF-transfected OL cultures at 2 days differentiation. RNA from brain, heart, and cultured astrocyte
samples are provided for positive and negative controls, respectively.
(F and G) Results of GeneChip analysis of gene expression in OPCs and OLs transfected with siCont or siMRF as OPCs then cultured for 2 days in differentiating
conditions.
(F) Downregulation of selected OPC markers NG2, PDGFRa, and Ki67 during differentiation is not affected by MRF knockdown.
(G) Expression of OL pan-OL lineagemarker Sox10, early-OLmarkers (Ugt8, CNP, PLP, andMBP), and late-OLmarkers (MAG, transferrin/Tfn, MOBP, andMOG)
in cells transfected with siMRF expressed as amean percentage of siCont-transfected OL values ±SEM. Results are averages of three independent experiments.
(H) Venn diagram showing overlap of genes induced >4-fold with differentiation and those repressed >4-fold by transfection with siMRF.Cldn11/OSP or cell cycle regulators was largely unaffected
(Figure 2H). These findings indicate that MRF is required for
the induction of most CNS myelin genes and many, albeit not
all, OL-specific genes involved in oligodendrocyte maturation.
Forced MRF Expression Induces Myelin Gene
Expression In Vitro and In Vivo
We next asked whether the expression of MRF was sufficient to
induce the expression of myelin genes. We transfected mouse
OPCs with a GFP expression plasmid together with either
a plasmid encoding MRF or an empty control vector and plated
them in media containing PDGF to maintain their growth as
OPCs. Cells transfected with the control vector (identified byGFPexpression) remainedNG2+,MBP/MOGOPCs (Figure 3A).
In contrast, MRF-transfected cells downregulated NG2, upregu-
lated MBP and MOG, and acquired a flattened morphology
(Figure S4). This effect was evident by 2 days posttransfection
and was more pronounced at 5 days posttransfection, by which
time approximately 80%of theMRF-transfected cells expressed
MBP and MOG (Figures 3B and 3C). In this assay, the induction
of MBP and MOG expression by MRF was considerably more
pronounced than that seen with Sox10, a gene that promotes
MBP expression and OL differentiation (Li et al., 2007; Stolt
et al., 2002).
To assess whether forced expression of MRF could also
induce myelin gene expression in vivo, we electroporated HHCell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc. 175
Figure 3. Forced MRF Expression Induces Myelin Gene Expression In Vitro and In Vivo
(A) Representative images of mouse OPCs cotransfected with eGFP and control (empty) vector, or vectors encoding MRF or Sox10 and then cultured for 2 days
posttransfection in proliferative conditions. Cells are stained for the OPC marker NG2 or OL markers MBP and MOG. Scale bar represents 50 mm.
(B and C) Quantification of the proportion of transfected cells in each condition expressing MBP (B) and MOG (C) at 2 and 5 days posttransfection. **p < 0.01,
unpaired t test. Values are means ± SEM.176 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.
stage 12–14 chick spinal cords with either a GFP plasmid or
GFP and MRF plasmids and analyzed the embryos 4 days later
at HH stage 27–28, prior to the normal differentiation of OLs
in the chick spinal cord (Zhou et al., 2001). Immunostaining
revealed scattered MBP+ cells on the electroporated side of
the spinal cord; such cells were never observed on the non-
electroporated side or in GFP-only electroporated controls
(Figures 3D and 3E). Misexpression of MRF in the chick spinal
cord induced MBP expression only in a small subset of GFP+
cells (ranging from 0% to 15.9% of GFP+ cells in various
animals, median = 1.6%), a phenotype that was different to
that seen in cultured mouse OPC, where forced MRF expres-
sion induced myelin gene expression in a high percentage of
cells. Interestingly, a high percentage (31.7%) of neural-crest-
derived cells that were electroporated with MRF (GFP+ and
Sox10+ cells outside the spinal cord) ceased to migrate shortly
after leaving the dorsal spinal cord and upregulated MBP
expression (Figures 3F and 3G). MBP expression in GFP+
neural crest cells was never observed in GFP-only-electropo-
rated embryos. These results suggested that these cells ex-
pressed transcription factors that in combination with MRF
induced MBP expression.
To investigate this possibility, we electroporated Sox10,
a neural crest marker, or Sox10 and MRF in chick spinal cord
and assayed MBP expression after 4 days. Sox10 electropora-
tion induced a larger number of MBP+ cells compared to MRF
electroporation (ranging from 9.3% to 61.9% of GFP+ cells in
different animals, median = 14.9%). However, coelectroporation
of MRF and Sox10 increased the number of MBP+ cells
compared to Sox10 alone (ranging from 20.9% to 65.8% of
GFP+ cells in different animals, median = 32.0%), but this differ-
ence was not statistically significant because of a high variability
in MBP induction between animals. These results indicate that
MRF is able to induce myelin gene expression in vivo as well
as in cultured OPC cultures, but may cooperate with other tran-
scription factors (e.g., Sox10) to promote myelination in vivo.
MRF Expression Is Necessary for CNS Myelination
To assess the role of MRF in mammalian CNS myelination, we
generated anMRF allele where exon 8 was flanked by loxP sites
(see Figure S5A for a description of the targeting vector). Exon 8
codes part of the predicted DNA binding region of MRF; as such,
Cre-mediated excision of exon 8was predicted to result in a trun-
cated protein lacking the DNA binding region and subsequent
C-terminal region of the protein resulting from a frame shift (Fig-
ure S5B). Initial experiments overexpressing this predicted post-
excision protein in OPCs confirmed that it had no ability to induce
myelin gene expression, unlike the full-length protein (data not
shown). We crossed the MRF loxP-flanked exon 8 (MRFfl/fl)
mice with an Olig2-Cre knockin mouse line (Schuller et al.,
2008) to effect recombination in glia including the OL lineagefrom an early developmental stage. We confirmed successful
deletion ofMRF exon 8 by RT-PCR of cDNA samples from spinal
cords and cultured OLs from MRF CKOs (Figure S9).
MRF conditional knockout (CKO) mice (MRFfl/fl; Olig2wt/cre)
were born at Mendelian frequencies and were not overtly distin-
guishable from control littermates (MRFwt/fl; Olig2wt/cre and
MRFfl/fl; Olig2wt/wt) for the first 10 days of life. From P11,
however, CKOs developed severe tremors and ataxia (Movie
S1), subsequently also developing seizures and dying during
the third postnatal week (Figure 4). Immunohistochemical anal-
ysis of the brains of CKO mice at P13 (Figure 4A) indicated that
NeuN and GFAP staining appeared normal and that the gross
CNS cytoarchitecture was not affected. In contrast, there was
a severe loss of staining for MBPwithin the brain, with only occa-
sional MBP+ oligodendrocytes seen within white matter tracts,
compared to near-ubiquitous MBP staining in the white matter
tracts of control mice. CKO spinal cords also showed a severe
loss of MBP immunostaining (Figure 4B), although the spinal
roots (myelinated by Schwann cells) still stained intensely for
MBP. As with the brains, NeuN and GFAP staining were unaf-
fected by the conditional deletion of MRF. Similarly, ChAT immu-
nostaining indicated that the motor neuron population was intact
in CKOs, indicating that disruption of the MRF gene does not
directly affect motor neurons (MNs are derived from Olig2+
progenitors and should undergo Olig2-Cre-mediated recombi-
nation). At higher magnification, some faintly MBP+ cells with
the morphology of premyelinating OLs could be seen in the
brains and spinal cords (Figures S6 and S7), suggesting that
the early stages of OL differentiation did occur in the absence
of MRF expression.
We confirmed loss of myelin protein expression in the CKO by
western blot of P13 spinal cord lysates, which demonstrated
substantially less MBP and CNP expression and a complete
loss of MOG expression in CKOs relative to control genotypes
(Figure 4C). Astrocyte and neuron proteins (GFAP and neurofila-
ment, respectively) were not affected in the CKO. To confirm
a loss of myelin proteins at other stages of development, we
harvested brains from CKOs and controls from P7 (at which
stage myelination in the brain is just beginning) to P17 (the latest
the CKOs could be reliably studied, because of their death). The
brains of control mice showed a substantial upregulation of the
proteins MBP, CNP, andMOG during this time; at all time points,
MBP and MOG were near undetectable in the CKOs (Figure 4D),
although some MBP expression was seen at very long expo-
sures (data not shown).
Fluoromyelin staining within CNS white matter tracts of CKOs
revealed a complete loss of myelination in CKO animals (Fig-
ure 4E). In contrast, peripheral nerves were equivalently myelin-
ated in both CKOs and controls as expected, as shown by the
fact that Schwann cells express neither MRF nor Olig2. We
confirmed the loss of myelination by electron microscopy in(D) Representative spinal cord sections of chicken embryos electroporated with expression constructs for MRF, Sox10, or both genes at E3 (stage 12) along with
a GFP construct and allowed to develop until E7. Sections are stained with anti-MBP, with GFP shown to identify electroporated cells.
(E) Quantification of the proportion of electroporated cells expressingMBP for each condition; shown are values for individual animals andmedian values for each
condition (red bars).
(F and G) Examples of MRF-electroporated neural crest cells ectopically expressing MBP (F); (G) shows triple labeling for GFP, MBP, and Sox10. The arrowhead
indicates a triple-labeled cell; a GFP/Sox10+, MBP cell can be seen to the left of the image.Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc. 177
Figure 4. MRF CKOs Display CNS Dysmyelination
(A and B) Representative images of the hippocampus, corpus callosum, and overlying cortex (A) and spinal cord (B) of control (MRFwt/fl; Olig2wt/cre) andMRFCKO
(MRFfl/fl; Olig2wt/cre) mice stained with MBP, NeuN, and GFAP at P13. ChAT staining of spinal cord motor neurons is shown in the inserts of (B).
(C) Western blot analysis of CNP, MBP, MOG, GFAP, and Neurofillament expression in the spinal cords of MRF control and CKO mice at P13.
(D) Developmental time-course of myelin gene expression in the brains ofMRF control (+) and CKO () mice with CKOs showing severe deficit in MBP and MOG
expression.
(E) Representative images of Fluoromyelin staining of the spinal cord lateral column white matter in a control (MRFwt/fl; Olig2wt/cre) and CKO (MRFfl/fl; Olig2wt/cre)
mouse at P13.
(F) Representative electron micrograph images of control and CKO optic nerves at P13. Control nerves show a significant amount of myelination in progress. In
contrast, essentially all axons in the CKOs lack myelin ensheathment (examples denoted by asterisk).
(G) Proportions of axons myelinated for control and CKOs are quantified.
(H) The lifespan of MRF CKOs is essentially limited to the third postnatal week.
Scale bars represent 1 mm in (A) and (B), 50 mm in (E), and 2 mm in (F). **p < 0.01.the optic nerves of CKOs; whereas control optic nerves were
actively myelinating by P13 with 50.7% ± 3.5% of axons having
two or more myelin wraps, virtually no myelination was observed
in the optic nerves of CKO littermates, and only 0.07 ± 0.07% of
axons were ensheathed (p < 0.001, Figures 4F and 4G). Impor-
tantly, we saw an equivalent phenotype (tremors, seizures, loss
of myelin gene expression/myelination and death in the third
postnatal week) when we crossed MRFfl mice with mice ex-
pressing Cre recombinase behind the CNP promoter (Lappe-178 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.Siefke et al., 2003), confirming that the CKO phenotype was
not dependent on the Olig2 heterozygous background caused
by insertion of the Cre gene (Figure S6).
OLs Differentiate inMRF CKO Mice but then
Undergo Apoptosis
To determine which populations of the OL lineage were affected
by the loss of MRF, we assessed the densities of OPCs and OLs
in P13 CKO and control littermate optic nerve sections
Figure 5. MRF CKOs Display a Loss of Mature OLs
(A) Immunostaining for MBP, CC1, NG2, GFAP, and Olig2 costained with CC1 and PDGFRa within the optic nerves of control (MRFwt/fl; Olig2wt/cre and MRFfl/fl;
Olig2wt/wt) and MRF CKO (MRFfl/fl; Olig2wt/cre) mice at P13. Scale bar represents 50 mm.
(B) Quantification of the density of Olig2 immunopositive nuclei within the optic nerves.
(C) Quantification of the density of Olig2+/CC1+ double-immunopositive OLs within the optic nerves.
(D) Quantification of the density of Olig2+/PDGFRa+ double-immunopositive OPCs within the optic nerves. All results are expressed asmeans ± SEM, n = 4–5 per
genotype. *p < 0.05, **p < 0.01.
(E) Densities of Olig2 immunopositive cells within the optic nerves of each genotype broken down into Olig2+ cells also positive for either CC1 (OLs), PDGFRa
(OPCs), or neither marker.(Figure 5A). We found a 45% reduction in the density of Olig2+
nuclei within the optic nerves of CKOs relative to control litter-
mates; this reduction was accounted for by the complete loss
of CC1+ cells (a marker of postmitotic OLs) in CKOmice (Figures
5B, 5C, and 5E). In contrast, the density of Olig2+ and PDGFRa+
cells (OPCs) was only modestly reduced (18.7%) in CKOs rela-
tive toMRFfl/fl; Olig2wt/wtmice (t test p < 0.05, but not significantly
different from MRFwt/fl; Olig2wt/cre controls; Figures 5D and 5E).
Therefore, the OPC stage was minimally affected in CKOs, an
observation supported also by normal NG2 staining. Similarly,
the density of Olig2+ cells negative for both CC1 and PDGFRa(presumably Olig2-expressing astrocytes) was similar between
genotypes (Figure 4E). AlthoughMBP staining was nearly absent
in the CKO optic nerves, a small number of weakly MBP+ cells
were present, suggesting that at least some postmitotic OLs
were generated in the CKO mice. The density of these faintly
MBP+ cells (35 ± 4 cells/mm2) was only 4% of the density of
mature OLs in the control mice, and they had the morphology
of premyelinating OLs, with thin, nonmyelinating processes
aligned with the axons.
To assess whether myelin or mature OLs were present in the
CKOs at earlier ages, we examined sagittal sections of the P7Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc. 179
CKO and control brains for MBP, CC1, and PDGFRa expression
(Figure S7). The density of OPCs was equivalent in control and
CKO mice in both areas studied at P7. Control littermates dis-
played a caudal to rostral gradient of myelination, with substan-
tial MBP expression in the hindbrain and cerebellum and scat-
tered MBP+ cells in the more rostral white matter tracts. In
contrast, only scattered faintly MBP+ cells were seen in the
CKOs and there was an almost complete absence of MBP or
CC1+ cells in the hindbrain (p < 0.01). Control mice displayed
a mix of premyelinating MBP+ OLs and myelinating OLs within
the corpus callosum at P7 when myelination is proceeding
(Figures S7E and S7F). In contrast, only premyelinating MBP+
but no myelinating OLs were observed in the corpus callosum
of CKO mice, indicating that the absence of MRF expression
caused a block in the transition from a premyelinating OL to
a mature, myelinating OL.
During development, approximately 50% of the postmitotic
OLs generated in the CNS undergo apoptosis (Barres et al.,
1992; Trapp et al., 1997). The extreme paucity of myelinating
OLs seen in CKO mice at P13 combined with the presence of
significant numbers of premyelinating OLs at P7 suggested
that in the absence of MRF, OLs may undergo apoptosis. We
observed that many weak MBP+ premyelinating OLs in the
CKOs displayed the characteristic morphology of apoptotic
OLs, with fragmented nuclei and blebbed processes. Staining
of optic nerves from P10 CKO and control mice with an antibody
against activated caspase-3, a marker of apoptosis, confirmed
a significant 2-fold increase in the density of apoptotic cells
in the CKO mice (p < 0.05, Figure S8). These data indicate that
postmitotic OLs are generated in the MRF CKO mice but then
undergo apoptosis.
Dysmyelination in MRF CKOs Is Cell Autonomous
and Not Solely due to Cell Death
It has been proposed that some premyelinating OLs undergo
apoptosis because they fail to receive axonal support. If MRF-
deficient OLs are unable to upregulate proteins required for inter-
actions with axons, this may explain their apoptosis in vivo. In
order to determine whether this is the case for MRF-deficient
cells, we cultured highly purified OPCs isolated from P7 control
and CKO mice. In the presence of PDGF, both control and CKO
OPCs proliferated as NG2 and Ki67+ cells, confirming that MRF
is not required for the OPC phase of the OL lineage (Figure 6A).
Upon withdrawal of PDGF, both control and CKO cells downre-
gulated Ki67, took on the morphology of OLs, and expressed
CNP (Figure 6B). However, CKO cells extended considerably
less extensive membrane sheets on the substrate compared to
control cells, and expressed low, barely detectable levels of
MBP. As in vivo, the MRF-deficient cells showed a significant
acceleration of cell death relative to the control genotypes, with
44.2% ± 2.9% ofMRFfl/fl; Olig2wt/cre cells viable at 4 days differ-
entiation, compared to 64.9% ± 0.5% ofMRFfl/fl; Olig2wt/wt cells
and 61.3% ± 1.4% of MRFwt/fl; Olig2wt/cre cells (Figures 6C and
6D, p < 0.01). This suggests that the increased apoptosis of
CKOOLs in vivomay not solely be due to a loss of axonal support
when these cells fail to myelinate, but premyelinating OLs
undergo an intrinsic apoptotic program if they cannot induce
myelin gene expression and myelinate.180 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.We analyzed RNA from control and CKO spinal cords and OL
cultures by RT-PCR and GeneChip microarrays. The expression
of many myelin genes such asMAG andMOBPwas abolished in
bothCKOspinal cords andOL cultures, demonstrating a require-
ment of MRF for the expression of these genes (Figures 6E–6G;
Table S1, Figure S7). Because of the substantial loss of OLs in
the CKO spinal cords, these samples displayed a loss of essen-
tially all genes specific to postmitotic OLs, whereas cultured
CKO cells showed more restricted deficits. The effects of MRF
deficiency on OL gene expression in vitro were very similar to
those we observed with siMRF knockdown (Figures 6E–6G;
Tables S1 and S2), with most myelin genes and many OL matu-
ration genes being strongly downregulated but only moderate
effects on several early OL genes such as Ugt8. Interestingly,
several genes such as p57/cdkn1cwhose expression is normally
limited to transient expression by newly formed oligodendro-
cytes were substantially upregulated in MRF-deficient OLs
in vitro, again consistent with the idea that in the absence of
MRF, OLs are stalled in the immature, premyelinating stage.
Although the increased apoptotic rate of CKO cells appeared
less severe than the deficits in myelin gene expression, it was
difficult to ascertain whether these cells undergo apoptosis
because of a blockade to transition toward a mature phase, or
whether the failure of myelin gene expression was secondary
to early apoptosis. To clarify this issue, we infected control and
CKO OPCs in vitro with a control adenovirus (Ad-GFP) or
a Bcl-2 adenovirus (Ad-Bcl-2) to block apoptosis, induced their
differentiation, and assayed survival and myelin protein expres-
sion at 2–8 days of differentiation (Figure 7). Infection of cells
with Ad-Bcl-2 (Figure 7A) successfully blocked the increased
apoptosis of CKO cells relative to control cells, with 74.7% ±
1.6% of control and 75.9% ± 1.9% of CKO cells (p > 0.05) re-
maining viable at 6 days of differentiation, a time at which nearly
all of the Ad-GFP-infected cells of both genotypes were dead
(15.5% ± 1.3% of control and 15.0% ± 2.4% of CKO cells being
viable; Figures 7B and 7C). In spite of the excellent viability of
both genotypes when infected with Ad-Cre, the CKO cells still
showed a clear deficit in myelin protein expression, whereas the
vast majority of control cells were positive for MBP (95.8% ±
1.9%), MAG (96.0% ± 1.7%), and MOG (94.3% ± 2.8%); only
71.5% ± 2.0% of CKO cells were faintly MBP+, and virtually
no CKO cells were positive for MAG (1.2% ± 0.5%) or MOG
(0.8% ± 0.3%). The CKO cells also still displayed a less mature
morphology than did control cells (Figure 7C) at 6 and 8 days
postdifferentiation, a time sufficient to induce the expression of
even late-phase myelin genes (Figures 7D–7H; Dugas et al.,
2006). Therefore, the apoptosis observed in MRF-deficient
OLs is likely to be a secondary effect because of their inability
to transition to a mature state.
DISCUSSION
MRF Is a Transcriptional Regulator of CNS Myelin Gene
Expression and Plays a Role in the CNS Comparable
to that of Krox-20 in the PNS
In this study, we have identified gene model 98/MRF as a tran-
scriptional regulator required for OL maturation and CNS myeli-
nation. MRF is not detectably expressed by OPCs, neurons, or
Figure 6. MRF-Deficient OPC/OL Cultures Display Deficiencies in Differentiative, but Not Proliferative, Conditions
(A and B) Immunostaining of control (MRFwt/fl; Olig2wt/cre) and CKO (MRFfl/fl; Olig2wt/cre) cultures for NG2 and Ki67 in proliferative (A) or differentiative (B) condi-
tions. Arrowheads indicate Ki67+ nuclei. The same cells stained for CNP and MBP are shown in (B).
(C) Representative images of control and CKO cells stained with calcein AM (green; live cells) and ethidium homodimer (red; dead cells) at 4 days differentiation
showing decreased viability and altered morphology of CKO cells.
(D) Quantification of viability of control and CKO cells at 1 to 4 days differentiation.
(E) Affymetrix expression levels of selected OPC markers NG2, PDGFRa, and Ki67 for control and CKO cells at 4 days differentiation; CKO cells display normal
downregulation of these markers.
(F) Expression levels of selected oligodendrocyte lineage markers in CKO cells at 4 days differentiation relative to control cells.
(G) Venn diagram showing overlap of genes induced >4-fold with OL differentiation and those repressed >4-fold in CKO relative to control cells.
(H) Schematic of transcriptional control of OL lineage specification and differentiation. MRF is required for the maturation of premyelinating OLs into mature OLs
expressing the full complement of myelin genes, with its induction possibly regulated by YY1.Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc. 181
Figure 7. Blocking Apoptosis Does Not Restore Myelin Gene Expression in MRF CKO Oligodendrocytes
(A) Confirmation of Bcl-2 overexpression in Ad-BCL-2-infected cells.
(B) Viability of control and CKO cells infected with Ad-GFP or Ad-Bcl-2 over 8 days in differentiation media.
(C) Calcien-AM/ethidium homodimer and phase images of Ad-Bcl-2-infected control and CKO cells at 6 days differentiation showing viability and morphology.
Arrowheads indicate dead cells.
(D) Expression of CNP, MBP, MAG, and MOG in Ad-Bcl-2-infected control and CKO cells at 6 days differentiation. Arrowheads indicate faintly MBP+ CKO cells.
(E–H)Quantificationof theproportionofAd-Bcl-2-infectedcontrolandCKOcellspositive forCNP,MBP,MAG,andMOGat2–8daysdifferentiation. *p<0.05, **p<0.01.182 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.
astrocytes and is upregulated strongly uponOL differentiation. In
the absence of MRF, OPCs are able to withdraw from the cell
cycle and differentiate into premyelinating OLs but are unable
to mature, express the full complement of myelin genes, or mye-
linate and instead undergo apoptosis.
Montano et al. (2002) suggest that the yeast transcriptional
activator Ndt80 may be the defining member of a family of tran-
scription factors sharing a conserved DNA binding domain that
includes MRF/GM98 and C11Orf9. Here, we confirm a role for
MRF inmyelin gene regulation in OLs, and thus CNSmyelination.
The high degree of homology between MRF and C11Orf9, in
addition to the ability of MRF to induce MBP expression in the
chick, suggests that its function is likely to be conserved
between mammalian and avian homologs. C11Orf9 mRNA is
downregulated in fetal motor neuron/oligodendroglial dysfunc-
tion in humans (Pakkasjarvi et al., 2005), indicating that it may
be expressed in OLs.
MRF’s role is distinct from that of other transcription factors
previously implicated in the OL lineage. MRF expression is
restricted to postmitotic OLs and is required for expression of
the vast majority of CNS myelin genes but not for OL specifica-
tion or differentiation per se. Several OL lineage transcription
regulators such as Nxk2.2, Olig1/2, Sox10, and YY1 are all
expressed by OPCs as well as OLs, or in other CNS cell types
(e.g., YY1). Although both MRF CKO and Olig1/ mice have
similar phenotypes with severe dysmyelination and death in
the third week postnatal, it is not clear whether OLs differentiate
in the Olig1/ mice (Xin et al., 2005). Similarly, analysis of the
spinal cords in Sox10/ embryos suggests a role for Sox10 in
promoting OL differentiation (Stolt et al., 2002). In contrast,
MRF CKOs contain substantial numbers of premyelinating OLs
at earlier ages but few myelinating OLs. Although Olig1 and
Sox10 can activate specific myelin genes (Li et al., 2007; Stolt
et al., 2002), Olig1 is not localized to the nucleus of myelinating
oligodendrocytes (Arnett et al., 2004), suggesting that it may
not directly induce myelin genes. So far, Nkx6.2 is the only tran-
scription factor shown to be specific to postmitotic OLs.
However Nkx6.2/ mice show surprisingly few myelin deficits,
with aberrations largely confined to the paranodal region (South-
wood et al., 2004), which contrasts with those seen in MRF
CKOs. Whereas the majority of transcription factors within the
OL lineage are critical for the specification of OPCs or initial
differentiation of OLs, MRF is unique in coordinating subsequent
maturation/myelination of postmitotic OLs.
The role of MRF in the CNS appears analogous to the role of
Krox-20 in the PNS. Krox-20 is expressed by myelinating
Schwann cells and is both sufficient and necessary to drive the
transition of a nonmyelinating Schwann cell to a myelinating
state (Nagarajan et al., 2001; Topilko et al., 1994), and activate
myelin gene promoters (Jang et al., 2006). As such, Krox-20
has been ascribed the role of a ‘‘master regulator’’ of PNS mye-
lination. However, Krox-20 is not expressed within the CNS.
The specificity of MRF expression to postmitotic OLs, both in
the newly formed and more mature stages, in combination
with the loss of myelin gene expression seen upon disruption
of MRF function, suggests that MRF may have a functionally
equivalent role to Krox-20 within the CNS. Interestingly, it is
possible that MRF and Krox-20 share a common molecularswitch that induces expression of both genes at the onset of
myelination. Krox-20 expression is induced by the transcrip-
tional regulator YY1 (He and Casaccia-Bonnefil, 2008). The
MRF gene contains a YY1 consensus site within a highly
conserved region in intron 1. Because YY1 has been shown to
link the exit of OPCs from the cell cycle with their differentiation
(He et al., 2007), the induction of MRF by YY1 or similar factors
upon OPC differentiation may be a mechanism by which cell
cycle exit is linked with OL differentiation and myelin gene
expression.
How Does MRF Induce Myelination?
HowdoesMRF inducemyelin gene expression andmyelination?
Given its nuclear localization and conservation of the DNA
binding domain with the yeast transcriptional activator Ndt80,
MRF may function as a transcription factor in OLs. Consistent
with this role, overexpression of a truncated form of MRF protein
lacking the DNA binding domain in cultured OPCs failed to
induce MBP expression (data not shown). Whether MRF func-
tions as a bona fide transcriptional activator is an important
question for future studies.
Although MRF is specific to OLs within the CNS, it is also ex-
pressed in other tissues such as lung and pancreas. Embryos
lacking MRF in all tissues from germline deletion of MRF via
a ubiquitous Cre driver failed to survive past E12.5 (data not
shown). This indicates that MRF has additional roles unrelated
to myelin gene expression outside the CNS. As such, MRF
may cooperate with other factors to specifically induce myelin
gene expression in OLs. Our observation that MRF overexpres-
sion in OPCs induced MBP and MOG in the majority of cells,
whereas it induced only a small number of MBP+ cells in the
spinal cord, strongly suggests that MRF may require other
factors (e.g., Sox10) to drive myelin gene expression.
Conversely, the confinement of MRF expression to the postmi-
totic phase of the OL lineage may explain why Sox10 (present
at all stages of the OL lineage) can induce myelin gene expres-
sion only in postmitotic cells. MRF may control the expression
of myelin genes directly by binding to their promoters, or alterna-
tively it may indirectly induce the transition to a myelinating state
by gating the expression of other transcription factors. Finally, in
addition to myelin genes, MRF is required for the expression of
a subset of other genes normally associated with OL maturation
including Adamts4 and TPPP, a tubulin polymerase. It is there-
fore possible that MRF induces a cohort of genes during OL
maturation that work together to assemble andwrap CNSmyelin
sheathes. Further analysis of MRF function and MRF-deficient
mice will provide insights into these processes of CNS myelina-
tion independent of OL differentiation.
EXPERIMENTAL PROCEDURES
All animal procedures were approved by Stanford University’s Administrative
Panel on Laboratory Animal Care.
Isolation and Culture of Mouse OPCs
Detailed protocols for the purification and culture of mouse OL lineage cells
are available upon request. Mouse OPCs were isolated from enzymatically
dissociated P7 mouse brains as described (Cahoy et al., 2008), positively im-
munopanned for PDGFRa after a depletion of microglia with BSL1. Cells wereCell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc. 183
grown in serum-free media as previously described (Dugas et al., 2006), but
with the addition of 2% B-27 (Invitrogen). PDGF-AA (10 ng/ml, PeproTech)
was added to the media to proliferate OPCs; PDGF-AAwas removed and triio-
dothyronine (T3) (40 ng/ml; Sigma) added to the media to induce differentia-
tion.
Transfections of OPCs
Cultures of mouse OPCs were passaged and resuspended to 503 106 cells/ml
in OPC Nucleofection solution (Amaxa). 100 ml (5 3 106 cells) was added to
expression plasmids (4 mg/transfection) or siRNAs (10 ml of 20 mM of siRNAs
against MRF or siControl nontargeting siRNApool) and electroporatedwith the
Amaxa nucleofection apparatus. See Supplemental Experimental Procedures
for more details.
Adenoviral Infection of OPCs
1millionOPCsof eachgenotypewere cultured inproliferativeconditions for 4 hr
in the presence of Ad-Bcl2 or Ad-GFP (Vector Biolabs) at anMOI of 100 in 10ml
ofmedia. After 4hr, themediawaschangedandcellswerepassaged intodiffer-
entiative conditions. Efficiency of infection was analyzed at 2 days after infec-
tion via GFP expression; infection efficiencies of >95% were obtained.
In Ovo Electroporations of Chick Embryos
Approximately 1 ml of DNA solutions (4 mg/ml of a 1:4 mix of pCIG and
pCAGGS-MRF and pCAGGS-Sox10 constructs) in TE buffer with 0.2% fast
green to permit visualization were injected into the neural tube of HH stage
12 embryos. Electroporation was performed as described (Zhou et al.,
2001). Embryos were harvested 4 days after electroporation and processed
for in situ hybridization or immunohistochemistry.
Immunohistochemistry
10 mm tissue cryosections or cells grown on PDL-coated coverslips were fixed
for 10min in 4%paraformaldehyde in PBS for 10min, washed in PBS, and then
incubated for 30 min in blocking solution (10% FCS in PBS for surface anti-
gens, with 0.3% triton-X for intracellular antigens). See Supplemental Experi-
mental Procedures for list of antibodies used. Coverslips or slides were
washed in PBS and incubated with the appropriate fluorophore-conjugated
secondary (Molecular Probes, 1:500 in blocking solution), washed in PBS,
and mounted in DAKO mounting medium with DAPI. Fluoromyelin (Invitrogen)
staining was performed on 10 mm cryosections according to manufacturer’s
instructions.
In Situ Hybridization
An in situ hybridization probe corresponding to 941 bp from the MRF 30 UTR
was amplified from OL cDNA with the primers GGTGGGTTTGAGTTTGGA
GGTT and GGGGAAACGCTCTATGAACAGG and subcloned into the PCR-II-
Topo vector (Invitrogen). The PLP probe was a kind gift of William Richardson.
In situ hybridizations were performed as described (Cahoy et al., 2008).
TEM Microscopy
Anesthetized P13 mice were perfused with PBS followed by 2% gluteralde-
hyde/4% paraformaldehyde in sodium cacodylate buffer. Optic nerves were
dissected out and postfixed overnight at 4C. After treatment with 1% osmium
tetroxide and 1% uranyl acetate, nerves were embedded in epon. Sectioning
and electron microscopy was performed at Stanford Microbiology and Immu-
nology Electron Microscopy Facility. Blind counts of myelinated axons were
performed on images of randomly selected areas of the optic nerves. At least
100 axons of 0.3 mm or greater diameter were counted from 5 images per
animal.
Northern Hybridization
Total RNA (5–15 mg) was run on a denaturing gel, transferred to Hybond-N+
(Amersham), and UV crosslinked. Membranes were prehybridized for 2 hr in
100 ml hybridization solution (7% SDS, 0.5 M Na2HPO4 [pH 7.2], 100 mg/ml
herring sperm DNA) at 68C. Radioactively labeled DNA probes were gener-
ated from plasmids containing approximately 1 kb of MRF, CNP, PLP, or
GAPDH cDNA with the Prime It II random Primer kit (Stratagene) as per manu-
facturer’s instructions with [a-32P]dCTP (GE Healthcare). Hybridization was184 Cell 138, 172–185, July 10, 2009 ª2009 Elsevier Inc.allowed to occur at 68C overnight, washed 23 10 min in 13SSC, 0.1% SDS
at RT then 33 10 min in 0.53SSC, 0.1% SDS at 68C. X-ray films (Amersham)
were then exposed to the membrane at 80C before being developed.
Affymetrix Analysis
Total RNA was isolated from cells with the RNeasy micro kit (QIAGEN, Valen-
cia, CA) with QIAGEN on-column DNase treatment to remove any contami-
nating genomic DNA. The integrity of RNA was assessed with an Agilent
2100 Bioanalyzer (Agilent Technologies) and RNA concentration was deter-
mined with a NanoDrop ND-1000 spectrophotometer (NanoDrop, Rockland,
DE). 1 mg total RNA was used for Affymetrix two-cycle target labeling and
430 2.0 Array hybridization according to manufacturer’s instructions, see
Supplemental Experimental Procedures for further details.
RT-PCR
RNA prepared as per above was subject to reverse transcription with Invitro-
gen Superscript III reverse transcriptase as per manufacturer’s instructions.
cDNA was subject to amplification for 25 or 30 cycles with gene-specific
primers and run on 2% agarose gels.
Generation of MRF CKO Mice
Mice in which exon 8 of MRF was flanked by loxP sites were generated my
cloning exon 8 into the Sal1 site of the pEZ-Frt-lox-DT targeting vector. A
5 kb 50 arm and 3 kb 30 arm were cloned into the Not1 and Xho1 sites, respec-
tively, to enable targeting of homologous recombination into E14 ES cell line.
Correctly targeted neomycin-resistant cloneswere identified by Southern blot-
ting of HindIII-digested DNA and PCR verification of the insertion of the 50 loxP
site. Targeted cells were injected into blastocytes to generate chimeric mice.
MRFwt/flmice were crossed onto the FlpER strain (Farley et al., 2000) to delete
the neomycin cassette. HeterozygousMRF floxed mice were crossed for two
generations onto Olig2-Cre mice (Schuller et al., 2008) or CNP-Cre mice
(Lappe-Siefke et al., 2003) to obtain MRFfl/fl; Olig2wt/cre or MRFfl/fl; CNPwt/cre
mice. See Supplemental Experimental Procedures for genotyping primers.
Quantification and Statistics
Blind counts of cultured cells were performed on at least 3 coverslips per
condition, with 10 fields of vision (203 objective) counted per coverslip. For
quantification of tissue sections, 4–6 mice were used per genotype. Three
sections were analyzed per mouse, with sections 60–100 mm apart photo-
graphed (320 objective) for analysis (areas of counted regions were quantified
in ImageJ). For quantification of activated Caspase 3+ cells, the number of im-
munopositive cells was quantified for 3 longitudinal optic nerve sections 60 mm
apart per mouse at 320 objective, the nerves were then photographed at low
power (34 objective), and areas of the nerves determined in ImageJ. Averages
were calculated for each coverslip or mouse, and these results used to calcu-
late means and SEMs for each experimental condition or genotype. Groups
were compared with unpaired 2-way t tests and Bonferroni’s correction for
multiple comparisons.
ACCESSION NUMBERS
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